About ArtusLabs
ArtusLabs is a Healthcare company based in Durham (United States) founded in 2007, and was acquired by PerkinElmer in March 2011. Data management software is provided for collaboration and drug discovery. ArtusLabs has raised $3.68 million across 3 funding rounds from investors including PerkinElmer. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include ScienceIO, Collaborative Drug Discovery and Qrativ; 2 of its 3 listed competitors have raised funding.
Company details
ArtusLabs was founded in 2007 and is based in Durham, United States. Software solutions for data management are offered by the company, targeting workplace collaboration and drug discovery processes. Tools such as social networking features, collaboration platforms, and scientific data mining capabilities are included to support research communication and management for internal and external users. Operations center on the biotechnology and software sectors.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Website artuslabs.com
- Social LinkedIn X
- Acquired by PerkinElmer (Mar 2011)
- Total Equity Funding$3.68M (USD)
in 3 rounds
- Latest Funding Round$600K (USD), Debt – Conventional
Sep 2010
- Investors
- Acquired byPerkinElmer
(Mar 2011)
Funding Insights of ArtusLabs
ArtusLabs has successfully raised a total of $3.68M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $600 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.68M
- Total Rounds 3
- Last Round Debt – Conventional — $600,000
- First Round $190,000
(Mar 2010)
All 3 funding rounds of ArtusLabs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | $600,000 | Debt – Conventional | – | – | – |
| Aug 2010 | $3.68M | Series A | – | – | – |
| Mar 2010 | $190,000 | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in ArtusLabs
ArtusLabs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for ArtusLabs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ArtusLabs
4 dated milestones of ArtusLabs across 4 years, from founding to its latest funding, stage changes and deals.
- Founded ArtusLabs is founded.
- Funding First funding round of $190K.
- Funding Latest funding round, Debt – Conventional, of $600K.
- Exit Acquired by PerkinElmer.
Competitors of ArtusLabs
ArtusLabs has 3 listed competitors in our database, 2 of them funded. They include ScienceIO, Collaborative Drug Discovery and Qrativ.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| science.io | 2020 | Boston, United States | $8M | 22 | Provider of AI solutions transforming medical text into enriched healthcare data | |
| collaborativedrug.com | 2004 | Burlingame, United States | 31 | Biological and chemical data are managed securely in a database. | ||
| qrativ.bio | 2017 | Cambridge, United States | $8.3M | AI based drug purposing platform to identify treatments for rare diseases |
Detailed competitors of ArtusLabs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ArtusLabs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ArtusLabs
ArtusLabs was founded in 2007 and raised its 1st funding round 3 years after it was founded.
ArtusLabs is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
ArtusLabs is a funded company, having raised a total of $3.68M across 3 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $190K, raised on Mar 2010.
ArtusLabs was founded in 2007 and is based in Durham, United States. Software solutions for data management are offered by the company, targeting workplace collaboration and drug discovery processes. Tools such as social networking features, collaboration platforms, and scientific data mining capabilities are included to support research communication and management for internal and external users. Operations center on the biotechnology and software sectors.
ArtusLabs's top competitors include ScienceIO, Collaborative Drug Discovery and Qrativ.
ArtusLabs has 1 investor. Key investors include PerkinElmer.
Yes. ArtusLabs was acquired by PerkinElmer in March 2011.